Editorial: GLP-1 receptor agonists in inflammatory bowel disease-Is it time?

被引:0
|
作者
Arvanitakis, Konstantinos [1 ,2 ]
Germanidis, Georgios [1 ,2 ]
机构
[1] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Internal Med 1, Div Gastroenterol & Hepatol, St Kiriakidi 1, Thessaloniki 54636, Greece
[2] Aristotle Univ Thessaloniki, Sch Med, Basic & Translat Res Unit, Special Unit Biomed Res & Educ,Fac Hlth Sci, Thessaloniki, Greece
关键词
D O I
10.1111/apt.18152
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
LINKED CONTENT This article is linked to Desai et al papers. To view this article, visit
引用
收藏
页码:658 / 659
页数:2
相关论文
共 50 条
  • [41] GLP-1 receptor agonists and heart failure in diabetes
    Scheen, Andre J.
    DIABETES & METABOLISM, 2017, 43 : 2S13 - 2S19
  • [42] GLP-1 receptor agonists for type 2 diabetes
    De Block, Christophe E. M.
    Van Gaal, Luc F.
    LANCET, 2009, 374 (9683): : 4 - 6
  • [43] Is cardioprotection with GLP-1 receptor agonists a class effect?
    Ryden, Lars
    Ferrannini, Giulia
    Mellbin, Linda
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (01) : 18 - 21
  • [44] Two New GLP-1 Receptor Agonists for Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1455): : 109 - 111
  • [45] Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists
    Alhiary, Rasha
    Kesselheim, Aaron S.
    Gabriele, Sarah
    Beall, Reed F.
    Tu, S. Sean
    Feldman, William B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (07): : 650 - 657
  • [46] GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
    Bezin, Julien
    Gouverneur, Amandine
    Penichon, Marine
    Mathieu, Clement
    Garrel, Renaud
    Hillaire-Buys, Dominique
    Pariente, Antoine
    Faillie, Jean-Luc
    DIABETES CARE, 2023, 46 (02) : 384 - 390
  • [47] Mapping the effectiveness and risks of GLP-1 receptor agonists
    Yan Xie
    Taeyoung Choi
    Ziyad Al-Aly
    Nature Medicine, 2025, 31 (3) : 951 - 962
  • [48] Why are GLP-1 receptor agonists in short supply?
    Bailey, Clifford J.
    BRITISH JOURNAL OF DIABETES, 2022, 22 (02): : 72 - 72
  • [49] GLP-1 receptor agonists: Targeting both hyperglycaemia and disease processes in diabetes
    Holst, Jens Juul
    Seino, Yutaka
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 85 (01) : 1 - 3
  • [50] GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists
    Gorriz, Jose Luis
    Jose Soler, Maria
    Navarro-Gonzalez, Juan F.
    Garcia-Carro, Clara
    Jesus Puchades, Maria
    D'Marco, Luis
    Martinez Castelao, Alberto
    Fernandez-Fernandez, Beatriz
    Ortiz, Alberto
    Gorriz-Zambrano, Carmen
    Navarro-Perez, Jorge
    Jose Gorgojo-Martinez, Juan
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)